Candid Therapeutics is continuing its mission to flesh out a pipeline of T-cell engagers in record time, signing a $925 million biobucks deal with WuXi Biologics for a preclinical candidate. The asset ...

In an industry where managing a web of technology vendors to support LO’s sales and marketing needs has become overwhelmingly complex, inefficient and creates unnecessary security and compliance risks ...

The device looks like a virtual-reality headset. But instead of covering people’s eyes, it peers into their mouths. A teledentistry startup — Candid — hopes the device can give it an edge in the ...

Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped three new research collaborations focusing on autoimmune diseases. The EpimAb ...

As of March 2022, this review is no longer being updated. It covers an older business model of Candid and some features mentioned may no longer be available. Candid is an online company that sends you ...

As of the end of 2023, Candid ceased all direct-to-consumer clear aligner products and services, and is no longer associated with this profile. In the two years following the announcement, Candid ...